Wendell Smith, MD
Family Medicine · Covington, GANPI 1578556619
Payments from drug & device makers
Across 193 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$414
- Lilly USA, LLC$397
- AstraZeneca$385
- GSK$363
- Pfizer$321
- Boehringer Ingelheim$207
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,566100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $414 |
| Lilly USA, LLC | 22 | $397 |
| AstraZeneca | 20 | $385 |
| GSK | 20 | $363 |
| Pfizer | 17 | $321 |
| Boehringer Ingelheim | 12 | $207 |
| Astellas Pharma US Inc | 8 | $180 |
| Bayer | 8 | $162 |
| Sanofi-aventis U.S. LLC | 7 | $127 |
| Edwards Lifesciences | 2 | $114 |
| Merck | 6 | $94 |
| Exact Sciences | 6 | $92 |
| AbbVie | 4 | $70 |
| Corcept Therapeutics | 3 | $60 |
| Abbott | 3 | $59 |
| Johnson & Johnson | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Dexcom, Inc. | 2 | $38 |
| Mylan Specialty L.p. | 2 | $35 |
| Exeltis, USA Inc. | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Amgen | 2 | $29 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Dynavax Technologies Corporation | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Atland Pharmaceuticals, LLC | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Avion Pharmaceuticals | 1 | $11 |
How this compares
$3,583 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 117 | $174,562 |
| MounjaroTirzepatide | 131 | $144,265 |
| JardianceEmpagliflozin | 78 | $91,175 |
| EliquisApixaban | 55 | $49,460 |
| FarxigaDapagliflozin Propanediol | 38 | $39,139 |
| LinzessLinaclotide | 34 | $37,214 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $35,363 |
| JanuviaSitagliptin Phosphate | 29 | $31,202 |
| TrulicityDulaglutide | 18 | $23,211 |
| BrilintaTicagrelor | 16 | $10,853 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $9,826 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 198 | $6,770 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $5,640 |
| Atorvastatin Calcium | 526 | $3,621 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $3,479 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $414 | $174,562117 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30 | $397 | $168,865162 claims |
| Boehringer IngelheimJardiance | $207 | $91,17578 claims |
| AstraZenecaFarxiga, Brilinta | $385 | $49,99254 claims |
| PfizerEliquis | $321 | $49,46055 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $363 | $45,18945 claims |
| AbbVieLinzess | $70 | $37,21434 claims |
| MerckJanuvia | $94 | $31,20229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Covington
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.